Feliciano Baldi

4.3k citations
76 papers · 3.4k indexed · h-index 34
Topics
Cancer-related Molecular Pathways (18 papers)RNA modifications and cancer (8 papers)Cardiac Fibrosis and Remodeling (7 papers)

In The Last Decade

Feliciano Baldi

75 papers receiving 3.3k citations

Peers

Feliciano Baldi
Comparison fields: 5 of 112
  • Molecular Biology 1.5k
  • Oncology 1.0k
  • Pulmonary and Respiratory Medicine 514
  • Cardiology and Cardiovascular Medicine 500
  • Surgery 377
Replace Tetsuji Sawada with:
Tetsuji Sawada Japan
Miguel Izquierdo Spain
Hisanori Uehara Japan
Ann M. Kapoun United States
Niki J. Agnantis Greece
Penelope Korkolopoulou Greece
Lin‐Hung Wei Taiwan
Deborah Damm United States
Libero Lauriola Italy
Feliciano Baldi relative to Tetsuji Sawada Japan Tetsuji Sawada's profile →
Citations per field
00.5×3.4×
Tetsuji Sawada · 1×
Citations per year

Countries citing papers authored by Feliciano Baldi

Since Specialization
Citations

This map shows the geographic impact of Feliciano Baldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feliciano Baldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feliciano Baldi more than expected).

Fields of papers citing papers by Feliciano Baldi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feliciano Baldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feliciano Baldi. The network helps show where Feliciano Baldi may publish in the future.

Co-authorship network of co-authors of Feliciano Baldi

This figure shows the co-authorship network connecting the top 25 collaborators of Feliciano Baldi. A scholar is included among the top collaborators of Feliciano Baldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feliciano Baldi. Feliciano Baldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 79
2 51
3 97
4 85
5 29
6 31
7 58
8 73
9 45
10 35
11 157
12 20
13 28
14 6
15 167
16 158
17 71
18 38
19 167
20 66

About Feliciano Baldi

Feliciano Baldi is a scholar working on Oncology, Biotechnology and Obstetrics and Gynecology, having authored 76 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (18 papers), RNA modifications and cancer (8 papers) and Cardiac Fibrosis and Remodeling (7 papers). The work is most often cited by research in Oncology (1.0k citations), Reproductive Medicine (287 citations) and Obstetrics and Gynecology (256 citations). Feliciano Baldi has collaborated with scholars based in Italy, United States and Austria. Frequent co-authors include Alfonso Baldi, Antonio De Luca, Vincenzo Esposito, Antonio Giordano, M Caputi, Rossana Bussani, Giovan Giacomo Giordano, Antonio Abbate, Marco G. Paggi and Furio Silvestri. Their work appears in journals such as Circulation, Nature Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026